HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Khalid Alhazzani Selected Research

brigatinib

11/2020Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Khalid Alhazzani Research Topics

Disease

21Neoplasms (Cancer)
03/2024 - 11/2017
8Inflammation (Inflammations)
12/2023 - 01/2021
6Breast Neoplasms (Breast Cancer)
11/2023 - 04/2018
3Autistic Disorder (Autism)
03/2024 - 01/2021
3Melanoma (Melanoma, Malignant)
12/2023 - 01/2022
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 10/2018
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 01/2019
2Leukemia
10/2023 - 06/2023
2Vascular System Injuries
10/2023 - 01/2019
2Neoplasm Metastasis (Metastasis)
10/2023 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 08/2022
2Pneumonia (Pneumonitis)
02/2023 - 01/2019
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2023 - 06/2021
2Cardiotoxicity
08/2022 - 09/2021
2Carcinogenesis
12/2021 - 01/2020
2Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 01/2019
1Neuroinflammatory Diseases
03/2024
1Infections
02/2024
1Triple Negative Breast Neoplasms
11/2023
1Asthma (Bronchial Asthma)
11/2023
1Hepatocellular Carcinoma (Hepatoma)
10/2023
1Hyperglycemia
08/2023
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2023
1Liver Diseases (Liver Disease)
06/2023
1Interstitial Lung Diseases (Interstitial Lung Disease)
02/2023
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Cardiomegaly (Heart Hypertrophy)
08/2022
1Glioblastoma (Glioblastoma Multiforme)
07/2022
1Glioma (Gliomas)
07/2022
1Colorectal Neoplasms (Colorectal Cancer)
06/2022

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
01/2024 - 12/2019
4AntioxidantsIBA
12/2023 - 06/2023
3Interleukin-6 (Interleukin 6)IBA
03/2024 - 02/2023
3CytokinesIBA
03/2024 - 01/2022
3Interleukin-17 (Interleukin 17)IBA
12/2023 - 02/2021
3Dasatinib (BMS 354825)FDA Link
10/2023 - 01/2023
3Tyrosine Kinase InhibitorsIBA
10/2023 - 08/2022
3Mitogen-Activated Protein KinasesIBA
01/2023 - 11/2017
2LipopolysaccharidesIBA
03/2024 - 06/2023
2Diethylhexyl Phthalate (DEHP)IBA
12/2023 - 01/2021
2phthalic acid (phthalate)IBA
12/2023 - 01/2021
2Oxidants (Oxidizing Agents)IBA
12/2023 - 11/2023
2Imiquimod (Aldara)FDA LinkGeneric
12/2023 - 01/2022
2Environmental Pollutants (Pollutants, Environmental)IBA
12/2023 - 01/2021
2EnzymesIBA
11/2023 - 08/2023
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 06/2022
2CalciumIBA
06/2023 - 02/2023
2ErbB Receptors (EGF Receptor)IBA
02/2023 - 08/2022
2Valsartan (Vals)FDA Link
02/2023 - 09/2021
2Angiotensin IIIBA
02/2023 - 08/2022
2Gefitinib (Iressa)FDA Link
02/2023 - 08/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2023 - 01/2019
2p38 Mitogen-Activated Protein KinasesIBA
08/2022 - 01/2022
2DNA (Deoxyribonucleic Acid)IBA
07/2022 - 01/2021
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2022 - 11/2017
2Metformin (Glucophage)FDA LinkGeneric
02/2022 - 12/2021
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
02/2022 - 12/2021
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022 - 11/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 12/2019
2PlatinumIBA
12/2019 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2019
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2019 - 11/2017
2Paclitaxel (Taxol)FDA LinkGeneric
04/2018 - 11/2017
1VancomycinFDA LinkGeneric
02/2024
1Anti-Bacterial Agents (Antibiotics)IBA
02/2024
1NitrogenIBA
01/2024
1Methotrexate (Mexate)FDA LinkGeneric
01/2024
1CarbonIBA
01/2024
1Etoposide (VP 16)FDA LinkGeneric
01/2024
1Two-Pore ChannelsIBA
12/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2023
1navitoclaxIBA
11/2023
1talazoparibIBA
11/2023
1AllergensIBA
11/2023
13-nitrotyrosineIBA
11/2023
1Sorafenib (BAY 43-9006)FDA Link
10/2023
1nilotinibFDA Link
10/2023
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2023
1cabozantinibIBA
10/2023
1Messenger RNA (mRNA)IBA
10/2023
1Streptozocin (Streptozotocin)FDA Link
08/2023
1LipidsIBA
08/2023
1diazobenzenesulfonic acid (DASA)IBA
06/2023
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
06/2023
1naringeninIBA
06/2023
1Dinoprostone (PGE2)FDA Link
06/2023
1Toll-Like Receptor 4IBA
06/2023
1ThapsigarginIBA
06/2023
1ChemokinesIBA
02/2023
1Reticulin (Reticular Fiber)IBA
01/2023
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
01/2023
1NF-kappa B (NF-kB)IBA
01/2023
1Type 1 Angiotensin ReceptorIBA
08/2022
1NADPH Oxidases (NAD(P)H oxidase)IBA
08/2022
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
07/2022
1Immune Checkpoint InhibitorsIBA
02/2022

Therapy/Procedure

10Therapeutics
03/2024 - 01/2019
4Drug Therapy (Chemotherapy)
11/2023 - 01/2019
1Radiotherapy
11/2023